Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.53B P/E - EPS this Y -328.60% Ern Qtrly Grth -
Income 49.27M Forward P/E 8.03 EPS next Y 51.90% 50D Avg Chg -3.00%
Sales 380.79M PEG -0.02 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book 4.34 EPS next 5Y 65.00% 52W High Chg -46.00%
Recommedations 2.70 Quick Ratio 5.02 Shares Outstanding 67.78M 52W Low Chg 44.00%
Insider Own 14.24% ROA 5.34% Shares Float 50.94M Beta -0.93
Inst Own 104.79% ROE 12.73% Shares Shorted/Prior 6.01M/4.37M Price 22.80
Gross Margin 59.66% Profit Margin 12.94% Avg. Volume 1,136,504 Target Price 4.25
Oper. Margin 1.78% Earnings Date May 10 Volume 815,083 Change -2.48%
About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Amylyx Pharmaceuticals, Inc. News
04/12/24 The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
04/10/24 Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
04/10/24 Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
04/10/24 Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
04/08/24 Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
04/06/24 Analysts Just Slashed Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) EPS Numbers
04/04/24 Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
04/04/24 ALS drug will be pulled from US market after study showed patients didn't benefit
04/04/24 UPDATE 1-Amylyx Pharma to remove ALS drug from US, Canada markets
04/04/24 Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market
04/04/24 Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy
04/04/24 Amylyx to pull ALS drug from market in rare move
03/27/24 European study finds popular ALS drug ineffective
03/14/24 3 Pharma Stocks to Sell in March Before They Crash & Burn
03/14/24 Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
03/14/24 Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors
03/13/24 Analysts on Wall Street Lower Ratings for These 10 Stocks
03/12/24 After surprise trial failure, ALS doctors brace for one less treatment option
03/11/24 Amylyx's (AMLX) ALS Drug Fails Pivotal Study, Stock Down 82%
03/11/24 Amylyx CEOs look for a path forward following major setback
AMLX Chatroom

User Image UncleStock Posted - 5 minutes ago

$AMLX $NCMI $SCYX $SBR suggested for Greenblatt - value screen: https://zpr.io/UTuPZph7JaaR

User Image sellhigh69 Posted - 3 hours ago

$AMLX does anyone know if they have insurance for the lawsuits? Thx.

User Image sellhigh69 Posted - 8 hours ago

$AMLX why wouldn’t some just buy them for 3-4 bucks and take the 5 bucks in cash. ?

User Image sellhigh69 Posted - 10 hours ago

$AMLX someone needs to wake up and buy this under cash. Business and technology, knowledge gets bought for free. Ridiculous

User Image Greenenergy33 Posted - 10 hours ago

$AMLX funding criminals in action day by day , now almost a third under cash

User Image thres Posted - 19 hours ago

$BCLI $amlx $clnn $seel The company remains sole proprietor of Nurown with international patents secured every corner of the earth, any spinal tap clinic can administer most of the treatment anywhere on the face of the earth. Nurown treatment and greater autonomyy vs Long term health care (big time $$$$). It is a no-brainer. Buy, buy, buy. Go Nurown, Nurown works.

User Image sellhigh69 Posted - 1 day ago

$AMLX Amylyx will continue to evaluate and share learnings from PHOENIX to help inform future ALS research. At this time, Amylyx intends to continue to collect available data on survival at the encouragement of ALS specialists. The PHOENIX Open Label Extension (OLE) is ongoing. Topline data from PHOENIX will be presented at the American Academy of Neurology (AAN) Annual Meeting in Denver and online, taking place April 13-18, 2024. The presentation is scheduled to occur on April 16, 2024, during the Clinical Trials Plenary Session (9:15 a.m. – 11:30 a.m. MT) and will be made available on the “Publications and Presentations” section of the Company’s website following the conclusion of the presentation.

User Image sellhigh69 Posted - 1 day ago

$AMLX yahoo states AMLX has 5.48 a share in cash. Is there a chance they can give cash to shareholders and shut dn operations?

User Image nUme22 Posted - 1 day ago

$MRNS $SPRB $EFTR $AMLX finally made some bucks with bargain hunting.. lol.

User Image sellhigh69 Posted - 1 day ago

$AMLX you would think with all their cash, and all their technology and knowledge it would be worth much more than this

User Image Dboy4realz Posted - 2 days ago

$AMLX bought this scumbag at $2.5 didn't know they would bleed it out this much

User Image nUme22 Posted - 2 days ago

$MRNS buying here...although all recent bargain buys have been trashes.. $SPRB, $EFTR , $AMLX let's see .. if this one works or not.

User Image Umutben11 Posted - 2 days ago

@sellhigh69 $AMLX Do we need to sell? What is the situation, friends?

User Image Umutben11 Posted - 2 days ago

$AMLX Do we need to sell? What is the situation, friends?

User Image Umutben11 Posted - 2 days ago

@ZdP2 Thank you very much for your help, 🙏 Unfortunately, the few shares I bought are in bad shape, I need to sell them with at least a small loss, these :) $AMLX , $IFBD, $ALT

User Image sellhigh69 Posted - 2 days ago

$AMLX Another presentation tomorrow? https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-formal-intention-to-remove-relyvrior/albriozatm-from-the-market-provides-updates-on-access-to-therapy-pipeline-corporate-restructuring-and-strategy

User Image Umutben11 Posted - 2 days ago

@ALSdrug $AMLX Hello mate, my average paper value is 3.52. What do you think I should do? I'm undecided whether to sell or not.

User Image ALSdrug Posted - 4 days ago

$AMLX review my posts from the 6 months about AMLX. On second thought don't. Told ya.

User Image ALSdrug Posted - 4 days ago

$AMLX Yo yo, here we go! $1 by next week! And then the big event comes soon when BCLI passes AMLX. The natual order of als will then be complete.

User Image Witsmuln Posted - 5 days ago

$AMLX s c a m.

User Image Witsmuln Posted - 5 days ago

$AMLX Worst stock of the last 30 days. Easy short!

User Image Greenenergy33 Posted - 5 days ago

$AMLX half of average volume per day and -10 % how ?how?

User Image Greenenergy33 Posted - 5 days ago

$AMLX just 5.5 dollars per share cash in hand. Zero debt and 200 millions income without amx0035. Falling without supports? Wtf is this artificial manipulation

User Image Cheaslea76 Posted - 5 days ago

$AMLX $1?

User Image Dboy4realz Posted - 5 days ago

$AMLX turn around and rip up you pos!

User Image kenny91655 Posted - 5 days ago

$AMLX question is how fast can they scale back operations. 1st quarter will be cash flow positive, 2nd will be awful.

User Image Greenenergy33 Posted - 5 days ago

$AMLX cash per share is 5.5. nonsense 😁😁😁😁 What world I am living in?

User Image TheBlackPanther Posted - 5 days ago

$AMLX Looks like this company is done for ever. Soon under $1 and finally CH11.

User Image Dboy4realz Posted - 5 days ago

$AMLX bought at $2.5 and as usual you know what happens after you buy. 🙄

User Image sellhigh69 Posted - 5 days ago

$AMLX where is insider buying?

Analyst Ratings
Baird Neutral Apr 11, 24
HC Wainwright & Co. Buy Apr 11, 24
HC Wainwright & Co. Buy Apr 8, 24
HC Wainwright & Co. Buy Mar 12, 24
Deutsche Bank Buy Mar 11, 24
Goldman Sachs Neutral Mar 11, 24
Leerink Partners Market Perform Mar 11, 24
Baird Neutral Mar 11, 24
Evercore ISI Group In-Line Mar 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Klee Justin B. Co-Chief Executive O.. Co-Chief Executive Officer Jan 09 Sell 16.3281 5,841 95,372 2,836,776 01/11/24
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer Jan 09 Sell 16.3281 2,716 44,347 112,035 01/11/24
Cohen Joshua B Co-Chief Executive O.. Co-Chief Executive Officer Jan 09 Sell 16.3281 5,841 95,372 2,900,470 01/11/24
Yeramian Patrick D Chief Medical Office.. Chief Medical Officer Jan 09 Sell 16.3281 2,812 45,915 205,605 01/11/24
Cohen Joshua B Co-Chief Executive O.. Co-Chief Executive Officer Nov 16 Option 1.57 63,694 100,000 2,906,311 11/20/23
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer May 16 Sell 27.26 32,500 885,950 55,676 05/18/23
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer May 16 Option 6.88 32,500 223,600 88,176 05/18/23
Yeramian Patrick D Chief Medical Office.. Chief Medical Officer Apr 17 Sell 30.74 49,579 1,524,058 208,417 04/19/23
Yeramian Patrick D Chief Medical Office.. Chief Medical Officer Apr 17 Option 3.63 49,579 179,972 257,996 04/19/23
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer Mar 16 Sell 32.16 32,500 1,045,200 34,009 03/24/23
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer Mar 16 Option 6.88 32,500 223,600 66,509 03/24/23
Yeramian Patrick D Chief Medical Office.. Chief Medical Officer Mar 16 Sell 32.14 54,627 1,755,712 199,250 03/24/23
Yeramian Patrick D Chief Medical Office.. Chief Medical Officer Mar 16 Option 2.53 49,578 125,432 253,877 03/24/23
Klee Justin B. Co-Chief Executive O.. Co-Chief Executive Officer Mar 16 Sell 32.16 100,000 3,216,000 2,792,617 03/20/23
MILNE GEORGE M JR Director Director Mar 16 Sell 32.15 35,000 1,125,250 862,021 03/20/23
Firestone Karen Director Director Mar 16 Buy 31.99 1,000 31,990 1,000 03/20/23
Cohen Joshua B Co-Chief Executive O.. Co-Chief Executive Officer Mar 16 Sell 32.14 100,000 3,214,000 2,792,617 03/20/23
Mazzariello Gina Chief Legal Officer Chief Legal Officer Feb 24 Sell 34.4874 3,586 123,672 37,414 02/28/23
Yeramian Patrick D Chief Medical Office.. Chief Medical Officer Jan 06 Sell 36.43 2,034 74,099 204,299 01/10/23
Cohen Joshua B Co-Chief Executive O.. Co-Chief Executive Officer Jan 06 Sell 36.43 5,968 217,414 2,892,617 01/10/23
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer Jan 06 Sell 36.43 2,658 96,831 34,009 01/10/23
Olinger Margaret Chief Commercial Off.. Chief Commercial Officer Jan 06 Sell 36.43 2,403 87,541 214,355 01/10/23
Klee Justin B. Co-Chief Executive O.. Co-Chief Executive Officer Jan 06 Sell 36.43 5,968 217,414 2,892,617 01/10/23
FRATES JAMES M Chief Financial Offi.. Chief Financial Officer Dec 30 Option 6.88 5,000 34,400 36,667 01/04/23
VIKING GLOBAL INVESTORS LP 10% Owner 10% Owner Sep 08 Sell 29.95 1,400,000 41,930,000 1,850,940 09/09/22
ALS Invest 1 B.V. 10% Owner 10% Owner Jul 06 Sell 20.97 60,609 1,270,971 5,895,280 07/08/22
Morningside Venture Investment... 10% Owner 10% Owner Jan 06 Buy 19 263,158 5,000,002 10,678,808 03/17/22
VIKING GLOBAL INVESTORS LP 10% Owner 10% Owner Jan 11 Buy 19 2,300,000 43,700,000 2,300,000 01/13/22
FONTEYNE PAUL R. Director Director Jan 06 Buy 19.00 3,947 74,993 3,947 01/10/22
Cheng Isaac Director Director Jan 06 Buy 19 6,578 124,982 6,578 01/10/22
MILNE GEORGE M JR Director Director Jan 06 Buy 19.00 26,315 499,985 221,396 01/10/22
Olinger Margaret Chief Commercial Off.. Chief Commercial Officer Jan 06 Buy 19 6,842 129,998 216,758 01/10/22